We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.69B
AUM Growth
-$187M
Cap. Flow
-$186M
Cap. Flow %
-11.04%
Top 10 Hldgs %
22.67%
Holding
154
New
18
Increased
32
Reduced
44
Closed
32

Top Buys

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$36M
2
PG icon
Procter & Gamble
PG
+$24.9M
3
GLW icon
Corning
GLW
+$18.7M
4
CARR icon
Carrier Global
CARR
+$17.4M
5
DD icon
DuPont de Nemours
DD
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Technology 14.49%
3 Financials 13.6%
4 Industrials 10.79%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
51
Ameriprise Financial
AMP
$47.4B
$16.5M 0.98%
53,770
-22,030
-29% -$7.22M
CAG icon
52
Conagra Brands
CAG
$7.3B
$16.4M 0.97%
+435,500
New +$16.1M
AEP icon
53
American Electric Power
AEP
$72.9B
$16.1M 0.96%
177,400
-62,100
-26% -$5.68M
DIS icon
54
Walt Disney
DIS
$168B
$15.6M 0.92%
155,330
-131,800
-46% -$13.3M
META icon
55
Meta Platforms (Facebook)
META
$1.51T
$15.4M 0.91%
+72,610
New +$12.4M
C icon
56
Citigroup
C
$221B
$15.2M 0.9%
324,240
+319,540
+6,799% +$15.7M
TMUS icon
57
T-Mobile US
TMUS
$193B
$14.8M 0.87%
+101,960
New +$14.8M
BMY icon
58
Bristol-Myers Squibb
BMY
$128B
$14.4M 0.85%
207,740
-235,320
-53% -$16.6M
EXC icon
59
Exelon
EXC
$48.4B
$14.1M 0.84%
337,610
+195,810
+138% +$8.16M
WMB icon
60
Williams Companies
WMB
$87.4B
$13.8M 0.82%
462,270
-324,500
-41% -$10M
SLB icon
61
SLB Ltd
SLB
$77.1B
$12.8M 0.76%
+261,200
New +$13.9M
VICI icon
62
VICI Properties
VICI
$29.6B
$12.5M 0.74%
382,950
+382,400
+69,527% +$12.6M
WH icon
63
Wyndham Hotels & Resorts
WH
$5.62B
$12.4M 0.74%
+183,300
New +$13.5M
MDLZ icon
64
Mondelez International
MDLZ
$78B
$12M 0.71%
172,770
+1,900
+1% +$126K
ZTS icon
65
Zoetis
ZTS
$32.4B
$12M 0.71%
+71,890
New +$11.8M
MPC icon
66
Marathon Petroleum
MPC
$91B
$11.7M 0.7%
+87,100
New +$10.9M
GOOGL icon
67
Alphabet (Google) Class A
GOOGL
$4T
$11M 0.65%
105,900
-83,900
-44% -$8.05M
FMC icon
68
FMC
FMC
$1.39B
$10.7M 0.63%
87,450
+19,150
+28% +$2.41M
HD icon
69
Home Depot
HD
$337B
$10.4M 0.61%
35,170
-53,700
-60% -$16.5M
PFE icon
70
Pfizer
PFE
$141B
$10.2M 0.6%
250,270
-243,720
-49% -$10.5M
CCI icon
71
Crown Castle
CCI
$32.3B
$9.3M 0.55%
69,500
+68,300
+5,692% +$9.44M
IGSB icon
72
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$9.15M 0.54%
181,051
-515
-0.3% -$25.9K
PSX icon
73
Phillips 66
PSX
$83.3B
$9.12M 0.54%
90,000
-89,900
-50% -$9.14M
MDT icon
74
Medtronic
MDT
$108B
$8.67M 0.51%
107,500
+106,000
+7,067% +$8.64M
LH icon
75
Labcorp
LH
$24.7B
$8.59M 0.51%
+43,592
New +$8.97M

Similar funds

Payden & Rygel's Q1 2023 Portfolio in Review

As of Q1 2023, Payden & Rygel held 154 positions worth $1.69B, down 10% from $1.88B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Payden & Rygel withdrew a net $186M in Q1 2023, closing 32 positions and reducing 44 holdings. Its most notable exit was Paychex, an estimated $27.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Payden & Rygel opened a new position in Amdocs worth $37.4M.

  • Payden & Rygel's largest Q1 2023 buy was Amdocs: 389,000 shares worth $37.4M.
  • Payden & Rygel added most to DuPont de Nemours in Q1 2023, an estimated $17.2M increase.
  • Payden & Rygel's biggest Q1 2023 reduction was CVS Health, cutting an estimated $36.2M.
  • Payden & Rygel fully exited Paychex in Q1 2023, selling an estimated $27.6M.
  • Payden & Rygel's ten largest holdings make up 23% of its $1.69B portfolio in Q1 2023.
  • Payden & Rygel opened 18 new positions and closed 32 in Q1 2023.
  • Payden & Rygel's portfolio value fell 10% quarter-over-quarter to $1.69B.

Based on Payden & Rygel's 13F filing for Q1 2023, filed 10 May 2023.